Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2025

May 5, 2025

284_dirs_2025-05-05_1ac69ac6-3e78-4564-8f0d-3888c65cda0d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2025-05-03

Reporting Person: Smart Dalton E. III (SVP Fin. - Global Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2025-05-03 Common Stock M 518 $83.18 Acquired 8850.802 Direct
2025-05-03 Common Stock F 256 $83.18 Disposed 8594.802 Direct
2025-05-03 Common Stock M 1532 $83.18 Acquired 10126.802 Direct
2025-05-03 Common Stock F 588 $83.18 Disposed 9538.802 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-05-03 Restricted Stock Unit $ M 518 Disposed 2025-05-03 Common Stock (518) Direct
2025-05-03 Restricted Stock Unit $ M 1532 Disposed 2025-05-03 Common Stock (1532) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in equal, annual installments with one installment having vested on 5/3/2024 and the last installment having vested on 5/3/2025.